These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15547020)

  • 1. Impact of nicorandil in angina: subgroup analyses.
    IONA Study Group
    Heart; 2004 Dec; 90(12):1427-30. PubMed ID: 15547020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of coronary events in patients with stable angina: results from the impact of nicorandil in angina study.
    IONA Study Group
    Am Heart J; 2005 Oct; 150(4):689. PubMed ID: 16209965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management.
    IONA Study Group
    Heart; 2001 Jun; 85(6):E9. PubMed ID: 11359763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial.
    IONA Study Group
    Lancet; 2002 Apr; 359(9314):1269-75. PubMed ID: 11965271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Yamada S; Kasuga H; Ichimiya S; Kanashiro M; Mitsuhashi H; Maruyama S; Matsuo S; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2007 Jan; 29(1):110-22. PubMed ID: 17379051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of the impact of nicorandil in angina (IONA) trial.
    Walker A; McMurray J; Stewart S; Berger W; McMahon AD; Dargie H; Fox K; Hillis S; Henderson NJ; Ford I
    Heart; 2006 May; 92(5):619-24. PubMed ID: 16614274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravenous nicorandil and preexisting angina pectoris on short- and long-term outcomes in patients with a first ST-segment elevation acute myocardial infarction.
    Ishii H; Ichimiya S; Kanashiro M; Amano T; Ogawa Y; Mitsuhashi H; Sakai S; Uetani T; Murakami R; Naruse K; Murohara T; Matsubara T
    Am J Cardiol; 2007 May; 99(9):1203-7. PubMed ID: 17478142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicorandil for angina--an update.
    Drug Ther Bull; 2003 Nov; 41(11):86-8. PubMed ID: 14658416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study.
    Meeter K; Kelder JC; Tijssen JG; Bucx JJ; Henneman JA; Kerker JP; Hugenholtz PG
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S59-66. PubMed ID: 1282178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects.
    Markham A; Plosker GL; Goa KL
    Drugs; 2000 Oct; 60(4):955-74. PubMed ID: 11085202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
    Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
    J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronary artery disease--a randomised, double-blind, placebo controlled, crossover trial.
    Budzyński J; Kłopocka M; Pulkowski G; Suppan K; Fabisiak J; Majer M; Swiatkowski M
    Int J Cardiol; 2008 Jul; 127(2):233-9. PubMed ID: 17689732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicorandil Versus Nitroglycerin for Symptomatic Relief of Angina in Patients With Slow Coronary Flow Phenomenon: A Randomized Clinical Trial.
    Sani HD; Eshraghi A; Nezafati MH; Vojdanparast M; Shahri B; Nezafati P
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):401-6. PubMed ID: 25701829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization.
    Patel DJ; Purcell HJ; Fox KM
    Eur Heart J; 1999 Jan; 20(1):51-7. PubMed ID: 10075141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction.
    Ishii H; Ichimiya S; Kanashiro M; Amano T; Imai K; Murohara T; Matsubara T
    Circulation; 2005 Aug; 112(9):1284-8. PubMed ID: 16116055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual high-grade angina after enhanced external counterpulsation therapy.
    McCullough PA; Henry TD; Kennard ED; Kelsey SF; Michaels AD;
    Cardiovasc Revasc Med; 2007; 8(3):161-5. PubMed ID: 17765644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
    Fox K; Ford I; Steg PG; Tendera M; Robertson M; Ferrari R;
    Eur Heart J; 2009 Oct; 30(19):2337-45. PubMed ID: 19720635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.
    Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J
    Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicorandil decreases cardiac events during and after noncardiac surgery.
    Kashimoto S; Seki M; Ishiguro T; Yoshioka H; Nagata O; Nishimura K; Kikuchi T; Yamada T; Iwade M; Omi A; Honda O; Sakamoto A; Ogihara Y; Fujimoto K; Nakaigawa Y; Kato J; Watanabe A; Nomura M; Takeda J
    J Clin Anesth; 2007 Feb; 19(1):44-8. PubMed ID: 17321926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome.
    Ruilope LM; Kirwan BA; de Brouwer S; Danchin N; Fox KA; Wagener G; Segura J; Poole-Wilson PA; Lubsen J;
    J Hypertens; 2007 Aug; 25(8):1711-8. PubMed ID: 17620970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.